Influenza 2009 pandemic H1N1 A/Lviv/N6/09_500HA

Instructions | Symbol Definitions | Lipid Tag Descriptions
(Asterisks that follow the names of certain probes indicate that predominant components are shown.)

Sort By Value
Display Errors

Textual Symbolic

Experiment Name	Influenza 2009 pandemic H1N1 A/Lviv/N6/09_500HA
Associated Publication	, ,
Analyte Name	A/Lviv/N6/09, H1N1 virus
Analyte Family	Viruses/Virus-like particles
Analyte Information	Beta-propiolactone inactivated pandemic A(H1N1) 2009 Influenza Virus isolated from a clinical specimen (a fatal case), propagated in MDCK cells and passaged solely in these cells. Haemagglutinin 222G in addition to the G155E mutation.
Concentration	500 HA units
Protocol	After blocking arrayed slides with 3% (w/v) bovine serum albumin (Sigma A8577), 0.02% Blocker Casein (Pierce) in 150mM sodium chloride and 5 mM calcium chloride, the suspension of the inactivated virus (500 HA titre) was assayed in the presence of 17.5 uM oseltamivir carboxylate (19C for 1 h). After fixation with 4% paraformaldehyde, bound viruses were detected using the rabbit anti-A/New Jersey/76 antiserum (1:200), followed by biotinylated Protein A (Sigma), 10 ug/ml, and Alexa Fluor-647-labeled streptavidin from Molecular Probes (1 ug/ml). As diluent the blocker solution was used.
Other Comments	Please note that the HA titre was measured under a different assay set up compared to that in publication PMID19741625. 2000 HA here equals to 100 HA in the abovementioned paper.